Blog new laser treatment helps to reduce the rate of. The laser intervention in early stages of agerelated macular degeneration lead study is an investigation of the safety and efficacy of subthreshold nanosecond laser treatment to slow the progression of intermediate agerelated macular degeneration amd. A breakthrough treatment approach, ellex 2rt retinal rejuvenation therapy retains the therapeutic benefits of laser therapy whilst eliminating the thermal tissue damage inherent in conventional retinal. The laser intervention in early stages of agerelated macular degeneration lead study is a 36month, multicenter, randomized, shamcontrolled trial. A new nanosecond laser used to treat agerelated macular degeneration amd will be officially launched in spain next month.
New nanosecond laser treatment alleviates macular degeneration. Professor robyn guymer, the lead 2rt principal investigator states. This was the conclusion of a study from the university of. Nanosecond laser trial the centre for eye research australia is conducting a world first randomised controlled trial of a new laser treatment for agerelated macular degeneration amd. The laser intervention in early stages of agerelated macular degeneration lead study is a 36month, multicenter, randomized, shamcontrolled trial conducted from 20122015 of 292. Nov 07, 2016 agerelated macular degeneration amd in its early stages may be reversed with laser treatment.
Wet macular degeneration is called wet because the blood vessels that invade the macular eye area leak fluid and blood causing harm to cellular parts of the eye. Subthreshold nanosecond laser snl treatment in intermediate. Laser intervention in early agerelated macular degeneration. The safety, changes in fundus characteristics and macular function in a cohort of participants with bilateral intermediate amd are reported. Nanosecondlaser application in intermediate amd 12month results of fundus appearance and macular function.
A for participants without coexisting reticular pseudodrusen rpd at baseline n. Preventing progression in nonexudative agerelated macular. Fletcher explained, it is hoped that this study will provide a basis for the. Guymer, mbbs, phd, zhichao wu, bappscoptom, phd, lauren ab.
A new nanosecond laser treatment for dry macular degeneration is being tested at the australian centre for eye research. Medical xpress a new, low impact low energy laser treatment for patients with early agerelated macular degeneration amd has produced positive results by reducing indicators of the. Have laser eye surgery if i have macular degeneration. It is hoped this new treatment will slow or reverse the effects of dry macular degeneration, one of the most common causes of vision loss in the aging population. A new doubleblind, randomized clinical trial is currently underway at the center for eye research australia cera to determine whether the 2rt nanosecond laser manufactured by ellex. It is done to treat agerelated macular degeneration amd.
Subthreshold nanosecond laser intervention in intermediate. Laser therapy for macular degeneration enhanced vision. The study also showed evidence that nanosecond laser treatment in one eye can also produce positive effects in the other untreated eye. Laser treatment of drusen to prevent progression to advanced. Nanosecond laser treatment for agerelated macular degeneration does not induce focal vision loss or new vessel growth in the retina. Purpose there is an urgent need for a more effective intervention to slow or prevent progression of agerelated macular degeneration amd from its early stages to visionthreatening late complications. Macular degeneration may respond to new laser therapy. Pdf subthreshold nanosecond laser intervention in age. Using an animal model that recapitulates the thickened bm seen in amd, the effect of nanosecond laser treatment on bm thickness and rpechoroidal gene expression was also characterized. The 2rt nanosecond laser system uses a laser pulse that lasts 3 ns to target the macular at the back of the eye. Agerelated macular degeneration amd is a significant cause of vision loss in aging patients.
In addition to effectively treating the disease, the new laser treatment spared retinal tissue, where current laser treatments tend to damage it. This study details the capacity of nanosecond laser. The retina is the layer of cells in the back of your eye that converts light into electrical signals. Two hundred ninetytwo participants with bilateral large drusen and without oct signs of atrophy. A breakthrough treatment approach, ellex 2rt retinal rejuvenation therapy retains the therapeutic benefits of laser therapy whilst eliminating the thermal tissue damage inherent in conventional retinal photocoagulation. The purpose of the study is to determine whether 2rt nanosecond laser therapy slows the progression to advanced agerelated macular degeneration. Estimated hazard ratio hr is from a model adjusted for baseline covariates in the intentiontotreat set n 292.
Nanosecond laser treatment for dry macular degeneration. Tom spurling, managing director of ellex, says that a finely tuned laser fires an incredibly short burst of light that agitates the structures in the eye to trigger a natural, cellularlevel healing response. Nov 19, 2014 the study also showed evidence that nanosecond laser treatment in one eye can also produce positive effects in the other untreated eye. Using a new lowenergy, highspeed laser, the symptoms of agerelated macular degeneration were reduced. Subthreshold nanosecond laser intervention in agerelated. Subthreshold, nanosecond pulsed laser treatment shows promise as a treatment for agerelated macular degeneration amd. Currently there is no cure for this type of macular degeneration. Laser photocoagulation is a type of laser surgery for the eyes. Professor robyn guymer, the lead 2rt principal investigator states, our research shows that application of 2rt treatment is safe and painless, and results in both improved visual function. Nanosecond laser therapy reverses pathologic and molecular. The laser intervention in early stages of agerelated macular degeneration lead study is a world. Ophthalmology laser maker ellex medical lasers adelaide, south australia is developing a nanosecond laserbased technology to painlessly intervene in earlystage agerelated macular degeneration amd. The laser intervention in early stages of agerelated macular degeneration lead study is a 36month, multicenter, randomized, sham.
Nov 19, 2014 medical xpress a new, low impact low energy laser treatment for patients with early agerelated macular degeneration amd has produced positive results by reducing indicators of the disease. If youve got the dry form now, its important to keep a check on your vision. The laser intervention in early stages of agerelated macular degeneration lead study is an investigation of the safety and efficacy of subthreshold nanosecond laser treatment to slow the. Laser intervention in early agerelated macular degeneration study lead the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Answer a twostep treatment in which a lightsensitive drug visudyne is used to damage the abnormal blood vessels. At present i have 2020 vision is what they are telling me. Purpose the laser intervention in early stages of agerelated macular degeneration lead study is an investigation of the safety and efficacy of subthreshold nanosecond laser treatment to slow.
Tom spurling, managing director of ellex, says that a finely tuned laser fires an incredibly short. The laser intervention in early stages of agerelated macular degeneration lead study 1 is a 36month, multicenter, randomized, sham. A highly anticipated trial using nanosecond laser technology to slow the progression of agerelated macular degeneration amd has yielded promising results the laser intervention in early agerelated macular degeneration lead trial studied 300 people with amd and compared the disease progression of those treated with the laser with those who were not. Agerelated macular degeneration amd is a leading cause of vision loss, characterized by drusen deposits and thickened bruchs membrane bm. Kaplanmeier failure plot showing progression to late agerelated macular degeneration for the subthreshold nanosecond laser snl and sham treatment groups separately. The laser intervention in early stages of agerelated macular degeneration lead study is a 36month, multicenter, randomized, shamcontrolled trial conducted from 20122015 of 292 participants with bilateral soft drusen, aka intermediate amd iamd, who underwent q 6month treatment with subthreshold nanosecond laser snl or sham treatment to the study eye. Subthreshold nanosecond laser snl treatment has shown promise in preclinical studies and a pilot study in intermediate amd iamd. Laser treatment reverses effects of early agerelated macular. The lead randomized controlled clinical trial robyn h. Mar 22, 2019 jobling ai, guymer rh, vessey ka, et al.
The aim of this study was to investigate the effects of laser treatment in humans and mice. Listing a study does not mean it has been evaluated by the u. Agerelated macular degeneration amd in its early stages may be reversed with laser treatment. Currently, the laser intervention in early agerelated macular degeneration study lead, a multicentre randomised clinical trial using a nanosecond laser to investigate progression of amd in 240 participants, is underway. Nanosecond laser therapy reverses pathologic and molecular changes in agerelated macular degeneration without retinal damage. A highly anticipated trial using nanosecond laser technology to slow the progression of agerelated macular degeneration amd has yielded promising results. Participants will be randomized to receive either the 2rt laser or a sham laser. Developed by australian company ellex, the 2rt laser will be launched at the european society of cataract and refractive surgeons escrs congress in barcelona in september.
A highly anticipated trial using nanosecond laser technology to slow the progression of agerelated macular degeneration amd has yielded promising results the laser intervention in early age. Agerelated macular degeneration in its early stages may be. How does photodynamic laser therapy treat agerelated macular degeneration. Agerelated macular degeneration vision loss changes have bee reduced by a new type of laser treatment, which does not damage the retina. New laser therapy helps slow macular degeneration sciencedaily. Retina rejuvenation therapy for diabetic macular edema. Subthreshold nanosecond laser intervention in agerelated macular degeneration the lead randomized controlled clinical trial. In addition to effectively treating the disease, the new laser treatment spared retinal tissue. Macular degeneration without retinal damage, the faseb journal 29, no. How does photodynamic laser therapy treat agerelated macular. Nov 20, 2014 agerelated macular degeneration vision loss changes have bee reduced by a new type of laser treatment, which does not damage the retina.
Developed by australian company ellex, the 2rt laser will be launched at the. A new doubleblind, randomized clinical trial is currently underway at the center for eye research australia cera to determine whether the 2rt nanosecond laser manufactured by ellex medical lasers ltd can be utilized to slow the progression of agerelated macular degeneration in patients with early stage amd. Laser treatments are sometimes helpful to limit damage to the macular although lasik eye surgery is not safe nor. It is hoped this new treatment will slow or reverse the effects of. Laser photocoagulation for agerelated macular degeneration. Robyn h guymer, zhichao wu, lauren ab hodgson, emily caruso, kate h brassington, nicole tindill, khin zaw aung, myra b mcguinness, erica l fletcher. What is laser photocoagulation for agerelated macular degeneration. Subthreshold nanosecond laser intervention in agerelated macular degeneration. Some people with the dry form of amd can develop the wet form.
660 780 218 720 797 1515 1219 40 345 1017 1462 615 1201 1513 362 242 931 1412 114 429 1148 177 295 753 426 1190 428 330 999 647 408 757 968 1499 87 1087 1302 1162